Impact of Supervised Exercise Training on Pulmonary Function Parameters, Exercise Capacity and Irisin Biomarker in Interstitial Lung Disease Patients

Overview

Journal Pak J Med Sci

Specialty General Medicine

Date 2020 Jul 25

PMID 32704295

Citations 4

Authors

Rahma Mohammad Alyami

Abdulrahman Mohammed Alhowikan

Abdullah Rashed Alharbi

Ghada Al-Nafisah

Affiliations

Soon will be listed here.

Abstract

Objectives: To assess the impact of supervised exercise training (SET) on pulmonary function Parameters, exercise capacity and Irisin biomarker in Interstitial Lung Disease (ILD) patients.

Methods: Ten (10)patients with ILD and 18 healthy controls of age between 30-40+ years were selected for 8-week SET program. Before and after SET all subjects performed exercise capacity six minutes' walk test (6MWT), heart rate (HR) changes were recorded, shortness of Breath Respiratory Questionnaire (SOBQ) was obtained and Irisin levels were measured by Enzyme-Linked Immunosorbent Assay (ELISA). This interventional study was carried out at Department of Physiology, Faculty of Medicine, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia, from October 2018 to February 2019.

Results: Mean six minutes' walk distance (6MWD) was 395 ± 68.4 m at 1st visit increased significantly (p=0.001) to 458.8± 87.1 mat 15 visit. However, 6MWD values found significantly higher in controls (517.4±84.1 m; 561.7±81.6 m; p=0.013) than ILD patients. Overall change (difference between post and pre exercise) in HRvalue was recorded lower in ILD patients (30-35 bpm) as compared to controls (40-45 bpm). Moreover, ILD patients had overall higher SOBQ score than controls. Pre SET Irisin levels of ILD patients (4.24 ±1.73 pg/ml) and controls (3.43 ±1.04pg/ml) were found unchanged dafter SET (4.48±2.02pg/ml, 3.39 ±1.41pg/ml, p=0.677, p=0.093)respectively. However, patients Irisin values were found higher as compared to controls before and after SET.

Conclusion: Exercise capacity and Dyspneain patients with ILD were improved after 8-week of SET program. No major changes in Irisin levels among patients with ILD and controls were observed. Additional research requires to be carried out on large number of subjects to deter Minutese the advantages of exercise in ILD.

Citing Articles

The predictive effects of adiponectin and irisin hormones on diagnosis and clinical involvement of Sarcoidosis.

Kaya H, Boyaci H, Argun Baris S, Basyigit I, Ozsoy O, Maral Kir H BMC Pulm Med. 2024; 24(1):623.

PMID: 39695541 PMC: 11657727. DOI: 10.1186/s12890-024-03412-z.

Treadmill exercise with nanoselenium supplementation affects the expression of Irisin/FNDC5 and semaphorin 3A in rats exposed to cigarette smoke extract.

Arabzadeh E, Shirvani H, Masjedi M, Ghanei M, Hofmeister M, Rostamkhani F 3 Biotech. 2023; 14(1):4.

PMID: 38058362 PMC: 10695908. DOI: 10.1007/s13205-023-03849-9.

Effectiveness of precise and quantitative rapid pulmonary rehabilitation nursing program for elderly patients with lung cancer during the perioperative period: A randomized controlled trial.

Chen B, Yan X, Wang X, Mao Y Pak J Med Sci. 2023; 39(2):572-577.

PMID: 36950399 PMC: 10025742. DOI: 10.12669/pjms.39.2.7103.

Long-Term Effect of Exercise on Irisin Blood Levels-Systematic Review and Meta-Analysis.

Jandova T, Buendia-Romero A, Polanska H, Hola V, Rihova M, Vetrovsky T Healthcare (Basel). 2021; 9(11).

PMID: 34828485 PMC: 8618299. DOI: 10.3390/healthcare9111438.

References

Norheim F, Langleite T, Hjorth M, Holen T, Kielland A, Stadheim H . The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans. FEBS J. 2013; 281(3):739-49. DOI: 10.1111/febs.12619. View

Bolton C, Singh S, Walker P . Commentary: the British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 2013; 68(9):887-8. DOI: 10.1136/thoraxjnl-2013-203809. View

Vainshelboim B, Oliveira J, Yehoshua L, Weiss I, Fox B, Fruchter O . Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis. Respiration. 2014; 88(5):378-88. DOI: 10.1159/000367899. View

Huh J, Mougios V, Skraparlis A, Kabasakalis A, Mantzoros C . Irisin in response to acute and chronic whole-body vibration exercise in humans. Metabolism. 2014; 63(7):918-21. DOI: 10.1016/j.metabol.2014.04.001. View

Kurdiova T, Balaz M, Mayer A, Maderova D, Belan V, Wolfrum C . Exercise-mimicking treatment fails to increase Fndc5 mRNA & irisin secretion in primary human myotubes. Peptides. 2014; 56:1-7. DOI: 10.1016/j.peptides.2014.03.003. View

Loffler D, Muller U, Scheuermann K, Friebe D, Gesing J, Bielitz J . Serum irisin levels are regulated by acute strenuous exercise. J Clin Endocrinol Metab. 2015; 100(4):1289-99. DOI: 10.1210/jc.2014-2932. View

Spruit M, Polkey M, Celli B, Edwards L, Watkins M, Pinto-Plata V . Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2011; 13(3):291-7. DOI: 10.1016/j.jamda.2011.06.009. View

Spruit M, Pitta F, Garvey C, ZuWallack R, Roberts C, Collins E . Differences in content and organisational aspects of pulmonary rehabilitation programmes. Eur Respir J. 2013; 43(5):1326-37. DOI: 10.1183/09031936.00145613. View

Holland A, Hill C, Glaspole I, Goh N, McDonald C . Predictors of benefit following pulmonary rehabilitation for interstitial lung disease. Respir Med. 2011; 106(3):429-35. DOI: 10.1016/j.rmed.2011.11.014. View

10.

Raghu G, Collard H, Egan J, Martinez F, Behr J, Brown K . An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011; 183(6):788-824. PMC: 5450933. DOI: 10.1164/rccm.2009-040GL. View

11.

Biniaminov N, Bandt S, Roth A, Haertel S, Neumann R, Bub A . Irisin, physical activity and fitness status in healthy humans: No association under resting conditions in a cross-sectional study. PLoS One. 2018; 13(1):e0189254. PMC: 5790221. DOI: 10.1371/journal.pone.0189254. View

12.

Loveman E, Copley V, Colquitt J, Scott D, Clegg A, Jones J . The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluation. BMC Pharmacol Toxicol. 2014; 15:63. PMC: 4247619. DOI: 10.1186/2050-6511-15-63. View

13.

Dowman L, Hill C, Holland A . Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev. 2014; (10):CD006322. DOI: 10.1002/14651858.CD006322.pub3. View

14.

Alyami M, Jenkins S, Lababidi H, Hill K . Reliability and validity of an arabic version of the dyspnea-12 questionnaire for Saudi nationals with chronic obstructive pulmonary disease. Ann Thorac Med. 2015; 10(2):112-7. PMC: 4375739. DOI: 10.4103/1817-1737.150730. View

15.

Nygaard H, Slettalokken G, Vegge G, Hollan I, Whist J, Strand T . Irisin in blood increases transiently after single sessions of intense endurance exercise and heavy strength training. PLoS One. 2015; 10(3):e0121367. PMC: 4363689. DOI: 10.1371/journal.pone.0121367. View

16.

Fatouros I . Is irisin the new player in exercise-induced adaptations or not? A 2017 update. Clin Chem Lab Med. 2017; 56(4):525-548. DOI: 10.1515/cclm-2017-0674. View

17.

. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000; 161(2 Pt 1):646-64. DOI: 10.1164/ajrccm.161.2.ats3-00. View

18.

Sharp C, McCabe M, Hussain M, Dodd J, Lamb H, Adamali H . Duration of benefit following completion of pulmonary rehabilitation in interstitial lung disease-an observational study. QJM. 2016; 110(1):17-22. DOI: 10.1093/qjmed/hcw105. View

19.

Bonini M, Fiorenzano G . Exertional dyspnoea in interstitial lung diseases: the clinical utility of cardiopulmonary exercise testing. Eur Respir Rev. 2017; 26(143). PMC: 9489119. DOI: 10.1183/16000617.0099-2016. View

20.

Perakakis N, Triantafyllou G, Fernandez-Real J, Huh J, Park K, Seufert J . Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol. 2017; 13(6):324-337. PMC: 5878942. DOI: 10.1038/nrendo.2016.221. View